RANVYSO Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for RANVYSO with the United States Patent and Trademark Office. The USPTO has given the RANVYSO trademark a serial number of 79278472. The federal status of this trademark filing is IR RESTRICTED - US REG. CANCELLED - NO TRANSFORMATION FILED as of Friday, February 10, 2023. This trademark is owned by STADA Arzneimittel AG. The RANVYSO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans

Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes
ranvyso

General Information

Serial Number79278472
Word MarkRANVYSO
Filing DateWednesday, December 18, 2019
Status414 - IR RESTRICTED - US REG. CANCELLED - NO TRANSFORMATION FILED
Status DateFriday, February 10, 2023
Registration Number6422183
Registration DateTuesday, July 20, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
Goods and ServicesApplicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, February 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, February 14, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameSTADA Arzneimittel AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, February 3, 2023LIMITATION FROM THE IB EXAMINED AND ENTERED
Friday, February 3, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, January 9, 2023ASSIGNED TO PARALEGAL
Saturday, December 3, 2022LIMITATION OF GOODS RECEIVED FROM IB
Sunday, December 19, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, November 27, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 26, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 31, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, July 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, June 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Sunday, May 2, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 14, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 14, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 27, 2021EXPARTE APPEAL TERMINATED
Friday, March 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 26, 2021ASSIGNED TO LIE
Tuesday, March 23, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 23, 2021EX PARTE APPEAL-INSTITUTED
Tuesday, March 23, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, March 23, 2021EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, March 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 23, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 20, 2020LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, September 23, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 23, 2020FINAL REFUSAL E-MAILED
Wednesday, September 23, 2020FINAL REFUSAL WRITTEN
Friday, September 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 27, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 22, 2020LIMITATION OF GOODS RECEIVED FROM IB
Friday, April 10, 2020REFUSAL PROCESSED BY IB
Tuesday, March 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 24, 2020REFUSAL PROCESSED BY MPU
Wednesday, March 4, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 3, 2020NON-FINAL ACTION WRITTEN
Monday, March 2, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020APPLICATION FILING RECEIPT MAILED
Friday, February 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 13, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ranvyso disorders ocular angiogenesis medical diseases human pharmaceutical apparatus preparations droppers